Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Medical guidelines

Vol. 151 No. 0708 (2021)

Infective endocarditis: prevention and antibiotic prophylaxis

DOI
https://doi.org/10.4414/smw.2021.20473
Cite this as:
Swiss Med Wkly. 2021;151:w20473
Published
28.02.2021

Summary

The Swiss societies of Infectious Diseases, Pediatric Cardiology and Cardiology and the Pediatric Infectious Disease Group of Switzerland present the current update on infective endocarditis prophylaxis in a joint initiative. The major focus of the revised recommendations is a comprehensive prevention campaign for all patients at risk for infective endocarditis. Antibiotic prophylaxis is recommended only for individuals at high risk. Within this high-risk group there is a ranking order, and the conditions are presented accordingly. Antibiotic prophylaxis is no longer recommended for patients with unrepaired ventricular septal defects and patent ductus arteriosus. Recommendations for antibiotic prophylaxis for the prevention of infective endocarditis are categorized in dental and non-dental interventions.

References

  1. Vernazza P, Tschudin Sutter S, Kronenberg A, Hauser C, Huttner B, Manuel O, et al. Entwicklung infektiologischer Guidelines – ein kontinuierlicher Prozess. Swiss Med Forum. 2018;18(46):963–5. doi:.https://doi.org/10.4414/smf.2018.03382
  2. Jaussi A, Flückiger U. Revidierte schweizerische Richtlinien für die Endokarditis-Prophylaxe. Kardiovaskuläre Medizin. 2008;11(12):392–400. doi:.https://doi.org/10.4414/cvm.2008.01375
  3. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128. doi:.https://doi.org/10.1093/eurheartj/ehv319
  4. Thornhill MH, Jones S, Prendergast B, Baddour LM, Chambers JB, Lockhart PB, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J. 2018;39(7):586–95. doi:.https://doi.org/10.1093/eurheartj/ehx655
  5. Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2015;385(9974):1219–28. doi:.https://doi.org/10.1016/S0140-6736(14)62007-9
  6. Thornhill MH, Gibson TB, Cutler E, Dayer MJ, Chu VH, Lockhart PB, et al. Antibiotic Prophylaxis and Incidence of Endocarditis Before and After the 2007 AHA Recommendations. J Am Coll Cardiol. 2018;72(20):2443–54. doi:.https://doi.org/10.1016/j.jacc.2018.08.2178
  7. Geach T. Infective endocarditis rises as prophylactic antibiotic use falls. Nat Rev Cardiol. 2015;12(1):5. doi:.https://doi.org/10.1038/nrcardio.2014.200
  8. Duval X, Hoen B. Prophylaxis for infective endocarditis: let’s end the debate. Lancet. 2015;385(9974):1164–5. doi:.https://doi.org/10.1016/S0140-6736(14)62121-8
  9. Bikdeli B, Wang Y, Krumholz HM. Infective endocarditis and antibiotic prophylaxis. Lancet. 2015;386(9993):528–9. doi:.https://doi.org/10.1016/S0140-6736(15)61467-2
  10. Bikdeli B, Wang Y, Kim N, Desai MM, Quagliarello V, Krumholz HM. Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol. 2013;62(23):2217–26. doi:.https://doi.org/10.1016/j.jacc.2013.07.071
  11. Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in Infective Endocarditis in California and New York State, 1998-2013. JAMA. 2017;317(16):1652–60. doi:.https://doi.org/10.1001/jama.2017.4287
  12. Shah ASV, McAllister DA, Gallacher P, Astengo F, Rodríguez Pérez JA, Hall J, et al. Incidence, Microbiology, and Outcomes in Patients Hospitalized With Infective Endocarditis. Circulation. 2020;141(25):2067–77. doi:.https://doi.org/10.1161/CIRCULATIONAHA.119.044913
  13. Swissnoso. Nationales Zentrum für Infektionsprävention. Sample-Guideline: perioperative Antibiotikaprophylaxe. Available at: https://www.swissnoso.ch/fileadmin/module/ssi_intervention/Dokumente_D/4_Sample_Guidelines/180816_Sample-Guideline_AMP_de.pdf.
  14. Schweizerische Gesellschaft für Gastroenterologie; Société Suisse de Gastroentérologie; Societa Svizzera di Gastroenterologia. Antibiotic Prophylaxis for Gastrointestinal Endoscopy. Available at: https://sggssg.ch/fileadmin/user_upload/Antibiotikaprophylaxe_in_der_Gastroenterologie_2018.pdf.
  15. Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, et al., International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914–56. doi:.https://doi.org/10.1016/j.healun.2010.05.034
  16. Wong RC, Abrahams Z, Hanna M, Pangrace J, Gonzalez-Stawinski G, Starling R, et al. Tricuspid regurgitation after cardiac transplantation: an old problem revisited. J Heart Lung Transplant. 2008;27(3):247–52. doi:.https://doi.org/10.1016/j.healun.2007.12.011
  17. Büchi A, Hoffmann M, Zbinden S, Atkinson A, Sendi P. The Duke minor criterion “predisposing heart condition” in native valve infective endocarditis - a systematic review. Swiss Med Wkly. 2018;148:w14675. doi:.https://doi.org/10.4414/smw.2018.14675
  18. Buechi AE, Hoffmann M. Infective endocarditis [Dr. med.]. Bern: University of Bern, 2017.
  19. Sherman-Weber S, Axelrod P, Suh B, Rubin S, Beltramo D, Manacchio J, et al. Infective endocarditis following orthotopic heart transplantation: 10 cases and a review of the literature. Transpl Infect Dis. 2004;6(4):165–70. doi:.https://doi.org/10.1111/j.1399-3062.2004.00074.x
  20. François M, Bingen EH, Lambert-Zechovsky NY, Mariani-Kurkdjian P, Nottet JB, Narcy P. Bacteremia during tonsillectomy. Arch Otolaryngol Head Neck Surg. 1992;118(11):1229–31. doi:.https://doi.org/10.1001/archotol.1992.01880110097017
  21. Kaygusuz I, Gök U, Yalçin S, Keleş E, Kizirgil A, Demirbağ E. Bacteremia during tonsillectomy. Int J Pediatr Otorhinolaryngol. 2001;58(1):69–73. doi:.https://doi.org/10.1016/S0165-5876(00)00471-7
  22. Yildirim I, Okur E, Ciragil P, Aral M, Kilic MA, Gul M. Bacteraemia during tonsillectomy. J Laryngol Otol. 2003;117(8):619–23. doi:.https://doi.org/10.1258/002221503768199951
  23. Klug TE, Henriksen JJ, Rusan M, Fuursted K, Ovesen T. Bacteremia during quinsy and elective tonsillectomy: an evaluation of antibiotic prophylaxis recommendations for patients undergoing tonsillectomy. J Cardiovasc Pharmacol Ther. 2012;17(3):298–302. doi:.https://doi.org/10.1177/1074248411423023
  24. Milder EA, Rizzi MD, Morales KH, Ross RK, Lautenbach E, Gerber JS. Impact of a new practice guideline on antibiotic use with pediatric tonsillectomy. JAMA Otolaryngol Head Neck Surg. 2015;141(5):410–6. doi:.https://doi.org/10.1001/jamaoto.2015.95
  25. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al.; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116(15):1736–54. doi:.https://doi.org/10.1161/CIRCULATIONAHA.106.183095

Most read articles by the same author(s)

1 2 3 > >>